Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes
- PMID: 40250147
- PMCID: PMC12163898
- DOI: 10.1016/j.yebeh.2025.110421
Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes
Abstract
Background & objective: Alzheimer's Disease (AD) patients at multiple stages of disease progression have a high prevalence of seizures. However, whether AD and epilepsy share pathophysiological changes remains poorly defined. In this study, we leveraged high-throughput transcriptomic data from sporadic AD cases at different stages of cognitive impairment across multiple independent cohorts and brain regions to examine the role of epilepsy-causing genes.
Methods: Epilepsy-causing genes were manually curated, and their expression levels were analyzed across bulk transcriptomic data from three AD cohorts and three brain regions. RNA-seq data from sporadic AD and control cases from the Knight ADRC, MSBB, and ROSMAP cohorts were processed and analyzed under the same analytical pipeline. An integrative clustering approach employing machine learning and multi-omics data was employed to identify molecularly defined profiles with different cognitive scores.
Results: We found several epilepsy-associated genes/pathways significantly dysregulated in a group of AD patients with more severe cognitive impairment. We observed 15 genes consistently downregulated across the three cohorts, including sodium and potassium channels genes, suggesting that these genes play fundamental roles in cognitive function or AD progression. Notably, we found 25 of these genes dysregulated in earlier stages of AD and become worse with AD progression.
Conclusion: Our findings revealed that epilepsy-causing genes showed changes in the early and late stages of AD progression, suggesting that they might be playing a role in AD progression. We can not establish directionality or cause-effect with our findings. However, changes in the epilepsy-causing genes might underlie the presence of seizures in AD patients, which might be present before or concurrently with the initial stages of AD.
Keywords: Alzheimer disease; Brain; Epilepsy; Multi-omics; Synaptopathy; Transcriptomics.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Update of
-
Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.medRxiv [Preprint]. 2025 Jan 31:2025.01.02.25319900. doi: 10.1101/2025.01.02.25319900. medRxiv. 2025. Update in: Epilepsy Behav. 2025 Jul;168:110421. doi: 10.1016/j.yebeh.2025.110421. PMID: 39974070 Free PMC article. Updated. Preprint.
Similar articles
-
Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.medRxiv [Preprint]. 2025 Jan 31:2025.01.02.25319900. doi: 10.1101/2025.01.02.25319900. medRxiv. 2025. Update in: Epilepsy Behav. 2025 Jul;168:110421. doi: 10.1016/j.yebeh.2025.110421. PMID: 39974070 Free PMC article. Updated. Preprint.
-
A Transcriptomics-Based Machine Learning Model Discriminating Mild Cognitive Impairment and the Prediction of Conversion to Alzheimer's Disease.Cells. 2024 Nov 19;13(22):1920. doi: 10.3390/cells13221920. Cells. 2024. PMID: 39594668 Free PMC article.
-
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.Neurobiol Dis. 2022 May;166:105655. doi: 10.1016/j.nbd.2022.105655. Epub 2022 Feb 8. Neurobiol Dis. 2022. PMID: 35143967 Free PMC article.
-
Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer's Disease.ACS Chem Neurosci. 2019 Oct 16;10(10):4199-4212. doi: 10.1021/acschemneuro.9b00460. Epub 2019 Sep 30. ACS Chem Neurosci. 2019. PMID: 31532186 Review.
-
Epileptic variant in the spectrum of Alzheimer's disease - practical implications.Seizure. 2025 May;128:133-139. doi: 10.1016/j.seizure.2024.09.015. Epub 2024 Sep 21. Seizure. 2025. PMID: 39343706 Review.
Cited by
-
Multi-omics: a bridge connecting genotype and phenotype for epilepsy?Biomark Res. 2025 Jun 18;13(1):86. doi: 10.1186/s40364-025-00798-8. Biomark Res. 2025. PMID: 40533803 Free PMC article. Review.
References
-
- Lam AD, Shafi MM. Towards a coherent view of network hyperexcitability in Alzheimer’s disease. Brain. 2022;145(2):423–5. - PubMed
-
- Canet G, Zub E, Zussy C, Hernandez C, Blaquiere M, Garcia V, et al. Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways. Epilepsia. 2022. Apr;63(4):919–35. - PubMed
-
- Dun C, Zhang Y, Yin J, Su B, Peng X, Liu L. Bi-directional associations of epilepsy with dementia and Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies. Age and ageing. 2022;51(3):afac010. - PubMed
-
- Beghi E, Giussani G, Costa C, DiFrancesco JC, Dhakar M, Leppik I, et al. The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly. Epilepsia. 2023. Mar;64(3):586–601. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical